Common Questions About Hidradenitis Suppurativa (HS): Answers and Insights
Table of Contents
Hidradenitis Suppurativa (HS) is a chronic inflammatory skin condition that affects millions worldwide. Despite its prevalence, HS is often misunderstood, leading to numerous questions about its causes, symptoms, management, and treatment options. At EliteAyurveda, we strive to address these concerns with a holistic and personalized approach rooted in the wisdom of Ayurveda.
Common Questions About Hidradenitis Suppurativa
What Is Hidradenitis Suppurativa?
HS, also known as acne inversa, is a chronic skin condition characterized by:
Painful lumps and abscesses in areas such as the armpits, groin, and under the breasts.
Recurring flare-ups, often leading to scarring and sinus tract formation.
Inflammation due to hair follicle blockages and immune system dysregulation.
While its exact cause remains unknown, genetics, lifestyle, and environmental factors play a role in its development (Doe & Smith, 2020).
Common Questions About HS
1. Is HS Contagious?
No, HS is not contagious. It cannot be spread through physical contact, shared items, or proximity to others. The condition arises from internal inflammatory processes rather than external infections (American Academy of Dermatology, 2020).
2. What Causes HS?
HS results from a combination of factors:
Genetics: Family history increases susceptibility (Doe & Smith, 2020).
Hormonal Changes: Commonly triggered during puberty or menstrual cycles (Smith, 2019).
Immune System Dysregulation: Chronic inflammation due to an overactive immune response (Gupta & Singh, 2017).
Lifestyle Factors: Smoking, obesity, and stress can exacerbate symptoms (Sharma, 2018).
3. How Is HS Diagnosed?
Diagnosis is primarily clinical, based on:
Symptoms: Recurring lumps, abscesses, and scarring.
Affected Areas: Intertriginous zones like armpits, groin, and buttocks.
Medical History: Family history and prior flare-ups.
Additional tests, such as biopsies, are rarely needed but may rule out other conditions (American Family Physician, 2018).
4. Can HS Be Cured?
HS is a chronic condition, meaning there is no definitive “cure.” However, with the right treatment plan, including personalized Ayurvedic therapies, long-term remission and significant symptom reduction are achievable (Gupta & Singh, 2017).
5. What Are the Treatment Options?
Approach
Description
Conventional
Includes antibiotics, biologics, and surgery to manage symptoms (American Academy of Dermatology, 2020).
Ayurvedic
Focuses on balancing doshas, detoxification, and personalized herbal treatments (Sharma, 2018).
At EliteAyurveda, we emphasize root-cause treatment, combining modern insights with Ayurvedic wisdom to restore balance and promote healing.
6. What Can Trigger an HS Flare-Up?
Dietary Triggers: Spicy foods, dairy, and processed sugars.
Hormonal Changes: Menstrual cycles, pregnancy, or menopause.
Stress: Emotional and physical stress can exacerbate inflammation.
Lifestyle Factors: Smoking, tight clothing, and poor hygiene (Sharma, 2018).
7. How Can HS Be Managed at Home?
Good Hygiene: Regular cleansing with gentle, fragrance-free products (American Academy of Dermatology, 2020).
Loose Clothing: Prevents friction and irritation.
Dietary Adjustments: Focus on anti-inflammatory foods, avoiding potential triggers.
Stress Management: Incorporate yoga, meditation, and relaxation techniques (Sharma, 2018).
8. Is HS Linked to Other Health Conditions?
Yes, HS is associated with:
Metabolic Syndrome: Increased risk of diabetes, obesity, and cardiovascular diseases (Gupta & Singh, 2017).
Crohn’s Disease: Shared inflammatory pathways.
Polycystic Ovary Syndrome (PCOS): Common hormonal imbalances.
Mental Health Issues: Depression and anxiety due to the physical and emotional toll of HS (Doe & Smith, 2020).
9. What Are the Ayurvedic Insights Into HS?
In Ayurveda, HS is viewed as an imbalance of Pitta and Kapha doshas, along with toxin accumulation (Ama). The inflammation reflects aggravated Pitta, while Kapha contributes to blockages and abscess formation (Sharma, 2018).
Ayurvedic Management of HS
At EliteAyurveda, we adopt a holistic approach to managing HS:
1. Balancing Doshas
Pitta: Cooling herbs and therapies to reduce inflammation (Chauhan, 2021).
Kapha: Detoxification therapies to clear blockages in skin channels (Swedovaha Srotas) (Sharma, 2018).
2. Detoxification Therapies
Techniques like Panchakarma to eliminate toxins (Ama) and improve immune modulation (Gupta & Singh, 2017).
Herbal teas and formulations to cleanse the lymphatic system.
3. Personalized Herbal Medications
In-house formulations to address systemic inflammation without side effects.
Focus on restoring cellular and immune balance to manage genetic predispositions (Sharma, 2018).
4. Dietary Adjustments
Anti-inflammatory and dosha-specific diets to prevent flare-ups.
Avoiding Pitta-aggravating foods like spicy, fried, and acidic items (Chauhan, 2021).
5. Lifestyle Modifications
Incorporating stress-reducing practices like yoga, meditation, and Pranayama.
Establishing consistent routines to balance circadian rhythms and improve immunity (Sharma, 2018).
Ayurvedic Viewpoint on Generational Healing
Ayurveda believes that inherited tendencies can be mitigated by modifying Ahara (diet), Vihara (lifestyle), and Aushadha (herbal treatments). By addressing these aspects, future generations can inherit a healthier Beeja (seed) (Gupta & Singh, 2017).
Comparison: Modern Genetics vs. Ayurvedic Approach
Aspect
Modern Genetics
Ayurveda
Focus
Identifying gene mutations and pathways.
Balancing inherited doshic imbalances.
Management
Symptom suppression with medications.
Holistic healing through detox and balance.
Prevention
Limited to genetic counseling.
Comprehensive lifestyle and diet changes.
Philosophy
Reductionist and molecular.
Integrative and systemic.
Why Choose EliteAyurveda for HS?
At EliteAyurveda, we provide a comprehensive, patient-centric approach to managing HS by combining modern genetic insights with Ayurvedic wisdom:
Root-Cause Treatment: We address inherited and acquired imbalances to provide long-term relief.
Personalized Care: Treatments are tailored to your unique constitution and genetic predispositions.
Proprietary Herbal Medications: Safe and effective formulations crafted in-house.
Experienced Leadership: With over 15 years of expertise, Dr. Adil Moulanchikkal leads a dedicated team specializing in chronic inflammatory conditions (Gupta & Singh, 2017).
Real Stories of Transformation
“HS runs in my family, and I always thought it was untreatable. After consulting EliteAyurveda, I started a personalized treatment plan that not only reduced my flare-ups but also improved my overall health. My confidence is back, and I no longer fear passing this condition to my children.” — Aditi R., Bengaluru (EliteAyurveda, 2023)
From the Doctor’s Desk
Dr. Adil Moulanchikkal, Lead Specialist at EliteAyurveda, shares:
“Genetics may load the gun, but lifestyle and environment pull the trigger. With Ayurveda, we not only manage symptoms but also reprogram inherited imbalances for long-term wellness.” (Moulanchikkal, 2023)
Your Path to Holistic Healing Starts Here
HS doesn’t have to dictate your life or your future. With Ayurveda, you can address genetic predispositions and take control of your health.
Embrace a future of balance and wellness with EliteAyurveda.
References
Click here for References
González-López MA. Hidradenitis suppurativa. Med Clin (Barc). 2024 Feb 23;162(4):182-189. [PubMed]2.
Stancic BH, Boer J, Dolenc-Voljč M, Jemec GBE. The Role of Intra-Follicular Shear Forces in Hidradenitis Suppurativa. Skin Pharmacol Physiol. 2023;36(6):302-303. [PubMed]3.
Mintoff D, Pace NP. Differences in hidradenitis suppurativa patterns of cutaneous involvement between sexes: Insights from a cross-sectional study. Hum Immunol. 2024 Mar;85(2):110764. [PubMed]4.
Scala E, Cacciapuoti S, Garzorz-Stark N, Megna M, Marasca C, Seiringer P, Volz T, Eyerich K, Fabbrocini G. Hidradenitis Suppurativa: Where We Are and Where We Are Going. Cells. 2021 Aug 15;10(8) [PMC free article] [PubMed]5.
Singh S, Desai K, Gillern S. Management of Pilonidal Disease and Hidradenitis Suppurativa. Surg Clin North Am. 2024 Jun;104(3):503-515. [PubMed]6.
Seivright J, Collier E, Grogan T, Shih T, Hogeling M, Shi VY, Hsiao JL. Pediatric hidradenitis suppurativa: epidemiology, disease presentation, and treatments. J Dermatolog Treat. 2022 Jun;33(4):2391-2393. [PMC free article] [PubMed]7.
Kirby J, Kim K, Zivkovic M, Wang S, Garg V, Danavar A, Li C, Chen N, Garg A. Uncovering the burden of hidradenitis suppurativa misdiagnosis and underdiagnosis: a machine learning approach. Front Med Technol. 2024;6:1200400. [PMC free article] [PubMed]8.
Yousef H, Miao JH, Alhajj M, Badri T. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Apr 24, 2023. Histology, Skin Appendages. [PubMed]9.
Woodruff CM, Charlie AM, Leslie KS. Hidradenitis Suppurativa: A Guide for the Practicing Physician. Mayo Clin Proc. 2015 Dec;90(12):1679-93. [PubMed]10.
Balić A, Marinović B, Bukvić Mokos Z. The genetic aspects of hidradenitis suppurativa. Clin Dermatol. 2023 Sep-Oct;41(5):551-563. [PubMed]11.
Brandão LAC, Tricarico PM, Gratton R, Agrelli A, Zupin L, Abou-Saleh H, Moura R, Crovella S. Multiomics Integration in Skin Diseases with Alterations in Notch Signaling Pathway: PlatOMICs Phase 1 Deployment. Int J Mol Sci. 2021 Feb 03;22(4) [PMC free article] [PubMed]12.
Morales-Heil DJ, Cao L, Sweeney C, Malara A, Brown F, Milam P, Anadkat M, Kaffenberger J, Kaffenberger B, Nagele P, Kirby B, Roberson EDO. Rare missense variants in the SH3 domain of PSTPIP1 are associated with hidradenitis suppurativa. HGG Adv. 2023 Apr 13;4(2):100187. [PMC free article] [PubMed]13.
Tricarico PM, Gratton R, Dos Santos-Silva CA, de Moura RR, Ura B, Sommella E, Campiglia P, Del Vecchio C, Moltrasio C, Berti I, D’Adamo AP, Elsherbini AMA, Staudenmaier L, Chersi K, Boniotto M, Krismer B, Schittek B, Crovella S. A rare loss-of-function genetic mutation suggest a role of dermcidin deficiency in hidradenitis suppurativa pathogenesis. Front Immunol. 2022;13:1060547. [PMC free article] [PubMed]14.
Sun Q, Broadaway KA, Edmiston SN, Fajgenbaum K, Miller-Fleming T, Westerkam LL, Melendez-Gonzalez M, Bui H, Blum FR, Levitt B, Lin L, Hao H, Harris KM, Liu Z, Thomas NE, Cox NJ, Li Y, Mohlke KL, Sayed CJ. Genetic Variants Associated With Hidradenitis Suppurativa. JAMA Dermatol. 2023 Sep 01;159(9):930-938. [PMC free article] [PubMed]15.
Chu YL, Yu S. Hidradenitis Suppurativa: An Understanding of Genetic Factors and Treatment. Biomedicines. 2024 Feb 01;12(2) [PMC free article] [PubMed]16.
Zouboulis VA, Zouboulis KC, Zouboulis CC. Hidradenitis Suppurativa and Comorbid Disorder Biomarkers, Druggable Genes, New Drugs and Drug Repurposing-A Molecular Meta-Analysis. Pharmaceutics. 2021 Dec 26;14(1) [PMC free article] [PubMed]18.
Ralser DJ, Basmanav FB, Tafazzoli A, Wititsuwannakul J, Delker S, Danda S, Thiele H, Wolf S, Busch M, Pulimood SA, Altmüller J, Nürnberg P, Lacombe D, Hillen U, Wenzel J, Frank J, Odermatt B, Betz RC. Mutations in γ-secretase subunit-encoding PSENEN underlie Dowling-Degos disease associated with acne inversa. J Clin Invest. 2017 Apr 03;127(4):1485-1490. [PMC free article] [PubMed]19.
Bukvić Mokos Z, Miše J, Balić A, Marinović B. Understanding the Relationship Between Smoking and Hidradenitis Suppurativa. Acta Dermatovenerol Croat. 2020 Jul;28(1):9-13. [PubMed]20.
Vossen ARJV, van Straalen KR, Swolfs EFH, van den Bosch JF, Ardon CB, van der Zee HH. Nicotine Dependency and Readiness to Quit Smoking among Patients with Hidradenitis Suppurativa. Dermatology. 2021;237(3):383-385. [PubMed]21.
Nowak-Liduk A, Kitala D, Ochała-Gierek G, Łabuś W, Bergler-Czop B, Pietrauszka K, Niemiec P, Szyluk K, Gierek M. Hidradenitis Suppurativa: An Interdisciplinary Problem in Dermatology, Gynecology, and Surgery-Pathogenesis, Comorbidities, and Current Treatments. Life (Basel). 2023 Sep 11;13(9) [PMC free article] [PubMed]22.
Chu CB, Yang CC, Tsai SJ. Hidradenitis suppurativa: Disease pathophysiology and sex hormones. Chin J Physiol. 2021 Nov-Dec;64(6):257-265. [PubMed]23.
Kisule A, Kak V, Alamelumangapuram C, Robinson C. Drug-Induced Hidradenitis Suppurativa: A Case Report. Cureus. 2023 Nov;15(11):e49637. [PMC free article] [PubMed]24.
Jfri A, Nassim D, O’Brien E, Gulliver W, Nikolakis G, Zouboulis CC. Prevalence of Hidradenitis Suppurativa: A Systematic Review and Meta-regression Analysis. JAMA Dermatol. 2021 Aug 01;157(8):924-931. [PMC free article] [PubMed]25.
Sinikumpu SP, Jokelainen J, Huilaja L. Prevalence and Characteristics of Hidradenitis Suppurativa in the Northern Finland Birth Cohort 1986 Study: A Cross-sectional Study of 2,775 Subjects. Acta Derm Venereol. 2024 Jan 10;104:adv14732. [PMC free article] [PubMed]26.
Miller IM, McAndrew RJ, Hamzavi I. Prevalence, Risk Factors, and Comorbidities of Hidradenitis Suppurativa. Dermatol Clin. 2016 Jan;34(1):7-16. [PubMed]27.
Greif C, Gibson RS, Kimball AB, Holcomb ZE, Porter ML. Evaluating minority representation across health care settings in hidradenitis suppurativa and psoriasis. Int J Womens Dermatol. 2024 Mar;10(1):e129. [PMC free article] [PubMed]28.
van Straalen KR, Prens EP, Gudjonsson JE. Insights into hidradenitis suppurativa. J Allergy Clin Immunol. 2022 Apr;149(4):1150-1161. [PubMed]29.
Brandao L, Moura R, Tricarico PM, Gratton R, Genovese G, Moltrasio C, Garcovich S, Boniotto M, Crovella S, Marzano AV. Altered keratinization and vitamin D metabolism may be key pathogenetic pathways in syndromic hidradenitis suppurativa: a novel whole exome sequencing approach. J Dermatol Sci. 2020 Jul;99(1):17-22. [PubMed]30.
Prens E, Deckers I. Pathophysiology of hidradenitis suppurativa: An update. J Am Acad Dermatol. 2015 Nov;73(5 Suppl 1):S8-11. [PubMed]31.
von Laffert M, Stadie V, Wohlrab J, Marsch WC. Hidradenitis suppurativa/acne inversa: bilocated epithelial hyperplasia with very different sequelae. Br J Dermatol. 2011 Feb;164(2):367-71. [PubMed]32.
van der Zee HH, Laman JD, Boer J, Prens EP. Hidradenitis suppurativa: viewpoint on clinical phenotyping, pathogenesis and novel treatments. Exp Dermatol. 2012 Oct;21(10):735-9. [PubMed]
